Cardiovascular System

Cardiovascular System

ISSN 2052-4358
Original Research

An alternative method that reduces homologous blood use In open heart surgery; cell saver

Melike Elif Teker1,2* and İ. Bayer Cınar2

*Correspondence: Melike Elif Teker melikelif_teker@hotmail.com

1. Biruni Unıversity Hospital, Department of Cardiovascular Surgery, İstanbul, Turkey.

Author Affiliations

2. Fatih Medical Park Hospital, Department of Cardiovascular Surgery, İstanbul, Turkey.

Abstract

Objective: Today the use of autologous blood or more effective use of the patient's own bloodespecially during heart surgeries which requires a significant amount of blood transfusion are being investigated since the use of homologous blood can lead to undesired results. In this study, we aimed to comparatively evaluate the effects of the cell saver device on the drainage, need for blood and blood products, postoperative infection complications and length of intensive care unit stay between patients in whom the device was and was not used.

Material and Method: 170 patients who underwent open heart surgery between January 2014 and December 2015 were studied. 85 of these patients constituted the control group (group 1) and 85 were the study group (group 2). The two groups were compared in terms of parameters such as the amount of blood lost postoperatively (drainage) through mediastinal drain, need for blood and blood products, length of intensive care unit stay and postoperative infections.

Results: For Group 1 and 2, mediastinal drainage amounts were 581±363 ml and 323±158 ml respectively, need for blood and blood products were 2.28 u and 1.03 u respectively, and lengths of intensive care unit stay were 28.9±1.5 hr versus 29.3±9.1 hr respectively.

Conclusion: Since the patient's own blood is used, the cell saver method involves no risk of homologous blood transfusion-related infections or development of any allergic reactions or complications. Moreover, since it can also be used in emergency surgeries, it provides comfort and confidence to the surgeon in patients in critical condition and in those with rare blood groups.

Keywords: Blood transfusion, heart surgery, cell saver, homologous blood, postoperative infection

ISSN 2052-4358
Volume 5
Abstract Download